enow.com Web Search

Search results

1. Results from the WOW.Com Content Network

2. Selamectin - Wikipedia

   en.wikipedia.org/wiki/Selamectin

   Selamectin, sold under the brand name Revolution, among others, is a topical parasiticide and anthelminthic used on dogs and cats. [2] It treats and prevents infections of heartworms , fleas , ear mites , sarcoptic mange (scabies), and certain types of ticks in dogs, and prevents heartworms, fleas, ear mites, hookworms , and roundworms in cats.

3. Sarolaner - Wikipedia

   en.wikipedia.org/wiki/Sarolaner

   Sarolaner is also an ingredient in feline combination antiparasitic Revolution Plus (or Stronghold Plus [12]), which contains sarolaner and selamectin and is used for prevention of sarcoptic mange, feline hookworms, feline roundworms, ear mites, and heartworms, as well as treating and preventing fleas and ticks.

4. Ornithonyssus bacoti - Wikipedia

   en.wikipedia.org/wiki/Ornithonyssus_bacoti

   [2] [3] [4] Pet rats are a natural host for mites, but other small mammals kept as pets (mice, hamsters, rabbits, guinea pigs, etc.) may also suffer infestation. To rid pets of the mite, selamectin is generally used in the form of Revolution, Stronghold or Pfizer. [2] Extermination of rats and other wild rodents which are common hosts is also key.

5. Nutritional supplements and vitamins are more popular than ...

   www.aol.com/nutritional-supplements-vitamins...

   Updated January 5, 2025 at 3:13 PM. Dietary supplements — vitamins, minerals, botanicals and probiotics — are more popular than ever. ... Lighten up your game day lineup with these healthy ...

6. Pfizer's (PFE) Prevnar 20 Plus Flu Vaccine Study Meets Goal - AOL

   www.aol.com/news/pfizers-pfe-prevnar-20-plus...

   Pfizer's (PFE) Prevnar 20 co-administered with a flu vaccine elicits non-inferior immunogenicity compared to administration of the vaccines one month apart in a late-stage study.

7. Pfizer moves forward with once-daily weight-loss pill - AOL

   www.aol.com/news/pfizer-moves-forward-once-daily...

   (Reuters) -Pfizer plans to move a reworked, once-a-day version of its weight-loss pill danuglipron into clinical trials later this year, the company said on Thursday, after scrapping a twice ...